Magnetic resonance imaging of the substantia nigra in Parkinson's disease
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Until recently, conventional magnetic resonance imaging (MRI) was most often negative in Parkinson's disease or showed nonspecific findings. Recent developments in structural MRI, including relaxometry, magnetization transfer, and neuromelanin imaging, have demonstrated improved contrast and enabled more accurate visualization of deep brain nuclei, in particular, the substantia nigra. Meanwhile, diffusion imaging has provided useful biomarkers of substantia nigra degeneration, showing reduced anisotropy and anatomical connectivity with the striatum and thalamus. These advances in structural imaging are complemented by findings of magnetic resonance spectroscopy on brain metabolism and resting‐state functional MRI on functional connectivity. This article presents an overview of these new structural, metabolic, and resting‐state functional MRI techniques and their implications for Parkinson's disease. The techniques are reviewed in the context of their potential for better understanding the disease in terms of diagnosis and pathophysiology and as biomarkers of its progression. © 2012 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147 · cited 1×
“followed by measurements of topographic features for the human cerebral cortex that takes as its starting point volumetric segmentation data.(33,37,38) Following cortical segmentation, a cortical ribbon of the cerebrum is obtained, and topographic measurements of the cortex can be calculated such as thickness, surface…”
BackgroundAGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Looking into the functional architecture of the brain with diffusion MRI.
Le Bihan, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1119 · Cited by 1,571 · cited 2×
“Factors such as membrane, myelin, longitudinal filaments, and cytoskeleton contribute, with membrane properties probably being the main contributor.(39) It is generally accepted that changes in axial diffusivity mainly reflect axonal damage, whereas changes in radial diffusivity reflect myelin damage.”
BackgroundMethodThe primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479 · cited 1×
“The SNr neurons predominantly project to the ventral thalamic nuclei and prefrontal cortex and receive afferents from the striatum, external globus pallidus, and subthalamic nucleus.(4,5) In the SN, damage is not uniform, as there is a preferential degeneration of dopaminergic neurons in the caudal and lateral substan…”
BackgroundEfferent connections of the substantia nigra and ventral tegmental area in the rat
Beckstead, R. M., Domesick, V. B., & Nauta, W. J. H. (1979) · Brain Research · doi:10.1016/0006-8993(79)91001-1 · Cited by 1,293
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
Redgrave, P., Rodriguez, M., Smith, Y., Rodriguez-Oroz, M. C., Lehericy, S., Bergman, H., Agid, Y., DeLong, M. R., & Obeso, J. A. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2915 · Cited by 1,134 · cited 2×
“In the SN, damage is not uniform, as there is a preferential degeneration of dopaminergic neurons in the caudal and lateral substantia nigra and their terminals in the caudolateral sensorimotor putamen.(6) In the classical model of PD, therefore, motor features appear as a result of preferential degeneration in sensor…”
BackgroundResultSasaki, M., Shibata, E., Tohyama, K., Takahashi, J., Otsuka, K., Tsuchiya, K., Takahashi, S., Ehara, S., Terayama, Y., & Sakai, A. (2006) · Neuroreport · doi:10.1097/01.wnr.0000227984.84927.a7 · Cited by 496 · cited 2×
“Similar reduction was observed in the LC area.(16)”
BackgroundResultPallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor
Helmich, R. C., Janssen, M. J. R., Oyen, W. J. G., Bloem, B. R., & Toni, I. (2011) · Annals of Neurology · doi:10.1002/ana.22361 · Cited by 417
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature
Péran, P., Cherubini, A., Assogna, F., Piras, F., Quattrocchi, C., Peppe, A., Celsis, P., Rascol, O., Démonet, J.-F., Stefani, A., et al. (2010) · Brain · doi:10.1093/brain/awq212 · Cited by 399
Cited by
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Parkinson's disease: Autoimmunity and neuroinflammation
De Virgilio, A., Greco, A., Fabbrini, G., Inghilleri, M., Rizzo, M. I., Gallo, A., Conte, M., Rosato, C., Ciniglio Appiani, M., & de Vincentiis, M. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.022 · Cited by 389
Schwarz, S. T., Afzal, M., Morgan, P. S., Bajaj, N., Gowland, P. A., & Auer, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093814 · Cited by 330
Biomarkers for Parkinson’s Disease: Recent Advancement
Lotankar, S., Prabhavalkar, K. S., & Bhatt, L. K. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0183-5 · Cited by 282
“The neuromelanin level can be measured by MRI techniques [90, 100], and it has been demonstrated to provide information on substantia nigra degeneration and is an essential biomarker for PD.”
BackgroundVisualization of nigrosome 1 and its loss in PD: Pathoanatomical correlation and in vivo 7 T MRI
Blazejewska, A. I., Schwarz, S. T., Pitiot, A., Stephenson, M. C., Lowe, J., Bajaj, N., Bowtell, R. W., Auer, D. P., & Gowland, P. A. (2013) · Neurology · doi:10.1212/wnl.0b013e31829e6fd2 · Cited by 269
Metadata
- Authors
- Lehéricy, S., Sharman, M. A., Santos, C. L. D., Paquin, R., & Gallea, C.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2012-05-30
- Volume
- 27
- Issue
- 7
- Pages
- 822-830
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2011843196
- Cited by
- 92
- References
- 11
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Magnetic resonance imaging of the substantia nigra in Parkinson's disease. https://app.cochat.ai/papers/10.1002/mds.25015
- The paper
- Lehéricy, S., Sharman, M. A., Santos, C. L. D., Paquin, R., & Gallea, C. (2012). Magnetic resonance imaging of the substantia nigra in Parkinson's disease. Movement Disorders. https://doi.org/10.1002/mds.25015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.